Literature DB >> 20461540

The positive predictive value of Borrelia burgdorferi serology in the light of symptoms of patients sent to an outpatient service for tick-borne diseases.

András Lakos1, Jeno Reiczigel, Norbert Solymosi.   

Abstract

OBJECTIVE: By using the published incidence of Lyme borreliosis in endemic regions of the World, and the sensitivity and specificity data of the best Lyme serological tests, we computed the positive predictive value of Borrelia burgdorferi antibody testing.
METHODS: The calculation of predictive value was based on Bayes' theorem. We also analyzed the frequency distribution of the specific and non-specific symptoms and complaints of 27,194 patients sent to the Centre for Tick-borne Diseases in Budapest from 1986 to 2008.
RESULTS: This evaluation demonstrated that practitioners often use Lyme serology in a "trial and error" way, without any reasonable ground. According to our calculation the positive predictive value of the best Lyme antibody tests if applied in this way is <9.1%.
CONCLUSION: Our study suggests that the present practice of applying Lyme serological tests may result in more harm than benefit.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20461540     DOI: 10.1007/s00011-010-0209-1

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  24 in total

Review 1.  Lyme disease.

Authors:  A C Steere
Journal:  N Engl J Med       Date:  2001-07-12       Impact factor: 91.245

2.  Seroprevalence of ehrlichiosis, Lyme borreliosis and tick-borne encephalitis infections in children and young adults in Slovenia.

Authors:  M Cizman; T Avsic-Zupanc; M Petrovec; E Ruzic-Sabljic; M Pokorn
Journal:  Wien Klin Wochenschr       Date:  2000-10-13       Impact factor: 1.704

3.  Tick-borne lymphadenopathy--a new rickettsial disease?

Authors:  A Lakos
Journal:  Lancet       Date:  1997-10-04       Impact factor: 79.321

4.  Interpretation by physicians of clinical laboratory results.

Authors:  W Casscells; A Schoenberger; T B Graboys
Journal:  N Engl J Med       Date:  1978-11-02       Impact factor: 91.245

5.  US national prevalence and correlates of low back and neck pain among adults.

Authors:  Tara W Strine; Jennifer M Hootman
Journal:  Arthritis Rheum       Date:  2007-05-15

6.  Prevalence of antibodies to Borrelia burgdorferi flagellin in Styrian blood donors.

Authors:  K Pierer; T Köck; W Freidl; D Stünzner; G Pierer; E Marth; H Lechner; J R Möse
Journal:  Zentralbl Bakteriol       Date:  1993-06

7.  Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II.

Authors:  Reva C Lawrence; David T Felson; Charles G Helmick; Lesley M Arnold; Hyon Choi; Richard A Deyo; Sherine Gabriel; Rosemarie Hirsch; Marc C Hochberg; Gene G Hunder; Joanne M Jordan; Jeffrey N Katz; Hilal Maradit Kremers; Frederick Wolfe
Journal:  Arthritis Rheum       Date:  2008-01

8.  Prospective study of serologic tests for lyme disease.

Authors:  Allen C Steere; Gail McHugh; Nitin Damle; Vijay K Sikand
Journal:  Clin Infect Dis       Date:  2008-07-15       Impact factor: 9.079

9.  An epidemiologic study of Lyme disease in southern Sweden.

Authors:  J Berglund; R Eitrem; K Ornstein; A Lindberg; A Ringér; H Elmrud; M Carlsson; A Runehagen; C Svanborg; R Norrby
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

10.  Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates.

Authors:  Rendi Murphree Bacon; Brad J Biggerstaff; Martin E Schriefer; Robert D Gilmore; Mario T Philipp; Allen C Steere; Gary P Wormser; Adriana R Marques; Barbara J B Johnson
Journal:  J Infect Dis       Date:  2003-04-02       Impact factor: 5.226

View more
  3 in total

1.  Borrelia burgdorferi sensu lato serology in the Netherlands: guidelines versus daily practice.

Authors:  J Coumou; J W R Hovius; A P van Dam
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-17       Impact factor: 3.267

2.  Poor Positive Predictive Value of Lyme Disease Serologic Testing in an Area of Low Disease Incidence.

Authors:  Paul M Lantos; John A Branda; Joel C Boggan; Saumil M Chudgar; Elizabeth A Wilson; Felicia Ruffin; Vance Fowler; Paul G Auwaerter; Lise E Nigrovic
Journal:  Clin Infect Dis       Date:  2015-07-20       Impact factor: 9.079

3.  Investigation of the performance of serological assays used for Lyme disease testing in Australia.

Authors:  Susan J Best; Marlene I Tschaepe; Kim M Wilson
Journal:  PLoS One       Date:  2019-04-29       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.